{"certainAgreement":{"otherDetails":"The information obtained from the clinical study will be used towards the development of ivosidenib and may be disclosed to regulatory authority(ies), other Investigators, corporate partners, or consultants as required.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"clinical.trial.management@servier.com","organization":"Servier Pharmaceuticals LLC","phone":"888-788-1735","title":"Medical Affairs"}}